PL1765337T3 - Połączenie tenofowiru, ritonawiru i TMC114 - Google Patents
Połączenie tenofowiru, ritonawiru i TMC114Info
- Publication number
- PL1765337T3 PL1765337T3 PL05774136T PL05774136T PL1765337T3 PL 1765337 T3 PL1765337 T3 PL 1765337T3 PL 05774136 T PL05774136 T PL 05774136T PL 05774136 T PL05774136 T PL 05774136T PL 1765337 T3 PL1765337 T3 PL 1765337T3
- Authority
- PL
- Poland
- Prior art keywords
- tenofovir
- ritonavir
- combination
- tmc114
- hiv
- Prior art date
Links
- NCDNCNXCDXHOMX-UHFFFAOYSA-N Ritonavir Natural products C=1C=CC=CC=1CC(NC(=O)OCC=1SC=NC=1)C(O)CC(CC=1C=CC=CC=1)NC(=O)C(C(C)C)NC(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-UHFFFAOYSA-N 0.000 title abstract 2
- 229960005107 darunavir Drugs 0.000 title abstract 2
- CJBJHOAVZSMMDJ-HEXNFIEUSA-N darunavir Chemical compound C([C@@H]([C@H](O)CN(CC(C)C)S(=O)(=O)C=1C=CC(N)=CC=1)NC(=O)O[C@@H]1[C@@H]2CCO[C@@H]2OC1)C1=CC=CC=C1 CJBJHOAVZSMMDJ-HEXNFIEUSA-N 0.000 title abstract 2
- 229960000311 ritonavir Drugs 0.000 title abstract 2
- NCDNCNXCDXHOMX-XGKFQTDJSA-N ritonavir Chemical compound N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-XGKFQTDJSA-N 0.000 title abstract 2
- 229960004556 tenofovir Drugs 0.000 title abstract 2
- VCMJCVGFSROFHV-WZGZYPNHSA-N tenofovir disoproxil fumarate Chemical compound OC(=O)\C=C\C(O)=O.N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N VCMJCVGFSROFHV-WZGZYPNHSA-N 0.000 title abstract 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical class OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 230000036436 anti-hiv Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Aiming, Guidance, Guns With A Light Source, Armor, Camouflage, And Targets (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04103256 | 2004-07-08 | ||
| PCT/EP2005/053266 WO2006005720A1 (en) | 2004-07-08 | 2005-07-08 | Combination of anti-hiv reverse transcriptase and protease inhibitors |
| EP05774136A EP1765337B1 (de) | 2004-07-08 | 2005-07-08 | Kombination aus tenofovir, ritonavir und tmc114 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1765337T3 true PL1765337T3 (pl) | 2009-02-27 |
Family
ID=34929311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05774136T PL1765337T3 (pl) | 2004-07-08 | 2005-07-08 | Połączenie tenofowiru, ritonawiru i TMC114 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20070208009A1 (de) |
| EP (1) | EP1765337B1 (de) |
| JP (1) | JP2008505870A (de) |
| CN (1) | CN1984654A (de) |
| AT (1) | ATE406161T1 (de) |
| AU (1) | AU2005261701A1 (de) |
| BR (1) | BRPI0513051A (de) |
| CA (1) | CA2572551A1 (de) |
| DE (1) | DE602005009366D1 (de) |
| DK (1) | DK1765337T3 (de) |
| ES (1) | ES2313394T3 (de) |
| HR (1) | HRP20080612T3 (de) |
| MX (1) | MXPA06014930A (de) |
| NZ (1) | NZ551841A (de) |
| PL (1) | PL1765337T3 (de) |
| RU (1) | RU2368380C2 (de) |
| SI (1) | SI1765337T1 (de) |
| WO (1) | WO2006005720A1 (de) |
| ZA (1) | ZA200700176B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008520672A (ja) * | 2004-11-16 | 2008-06-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | チプラナビルとダルナビルの共投与によるｈｉｖ感染症の治療方法 |
| EP2214668A1 (de) * | 2007-10-29 | 2010-08-11 | Cipla Limited | Neue antiretrovirale kombination |
| GT200800303A (es) | 2007-12-24 | 2009-09-18 | Combinacion anti-retroviral | |
| CN102876714A (zh) * | 2011-09-07 | 2013-01-16 | 深圳市易瑞生物技术有限公司 | 用慢病毒检测hiv耐药表型 |
| WO2013057469A1 (en) * | 2011-10-20 | 2013-04-25 | Cipla Limited | Pharmaceutical antiretroviral compositions |
| US10004721B2 (en) * | 2012-10-23 | 2018-06-26 | Cipla Limited | Pharmaceutical antiretroviral composition |
| WO2014184553A1 (en) * | 2013-05-15 | 2014-11-20 | Cipla Limited | Pharmaceutical antiretroviral compositions |
| HK1220390A1 (zh) * | 2013-08-29 | 2017-05-05 | Teva Pharmaceutical Industries Ltd. | 包括恩曲他滨，替诺福韦，达芦那韦和利托那韦的单位剂型以及包含达芦那韦和利托那韦的单体片剂 |
| EP3129009A1 (de) * | 2014-04-08 | 2017-02-15 | Teva Pharmaceutical Industries Ltd | Einheitsdosisform mit emtricitabin, tenofovir, darunavir und ritonavir |
| GB201509431D0 (en) * | 2015-06-01 | 2015-07-15 | Equigerminal Sa | Antiviral composition |
| US10213507B2 (en) * | 2017-03-10 | 2019-02-26 | The Florida International University Board Of Trustees | Compositions and methods for treating HIV-associated neurocognitive disorders |
| RU2662160C9 (ru) * | 2017-07-03 | 2018-10-22 | Александрович Иващенко Андрей | Комбинированный лекарственный препарат для терапии вирусных инфекций |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR037797A1 (es) * | 2001-12-12 | 2004-12-01 | Tibotec Pharm Ltd | Combinacion de inhibidores de proteasa dependientes del citocromo p450 |
-
2005
- 2005-07-08 CN CNA2005800230750A patent/CN1984654A/zh active Pending
- 2005-07-08 EP EP05774136A patent/EP1765337B1/de not_active Expired - Lifetime
- 2005-07-08 WO PCT/EP2005/053266 patent/WO2006005720A1/en not_active Ceased
- 2005-07-08 AU AU2005261701A patent/AU2005261701A1/en not_active Abandoned
- 2005-07-08 DE DE602005009366T patent/DE602005009366D1/de not_active Expired - Fee Related
- 2005-07-08 NZ NZ551841A patent/NZ551841A/en not_active IP Right Cessation
- 2005-07-08 SI SI200530488T patent/SI1765337T1/sl unknown
- 2005-07-08 PL PL05774136T patent/PL1765337T3/pl unknown
- 2005-07-08 AT AT05774136T patent/ATE406161T1/de not_active IP Right Cessation
- 2005-07-08 BR BRPI0513051-4A patent/BRPI0513051A/pt not_active IP Right Cessation
- 2005-07-08 DK DK05774136T patent/DK1765337T3/da active
- 2005-07-08 JP JP2007519807A patent/JP2008505870A/ja not_active Withdrawn
- 2005-07-08 MX MXPA06014930A patent/MXPA06014930A/es active IP Right Grant
- 2005-07-08 ES ES05774136T patent/ES2313394T3/es not_active Expired - Lifetime
- 2005-07-08 US US11/571,599 patent/US20070208009A1/en not_active Abandoned
- 2005-07-08 HR HR20080612T patent/HRP20080612T3/xx unknown
- 2005-07-08 CA CA002572551A patent/CA2572551A1/en not_active Abandoned
- 2005-07-08 RU RU2007104774/15A patent/RU2368380C2/ru not_active IP Right Cessation
-
2007
- 2007-01-05 ZA ZA200700176A patent/ZA200700176B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200700176B (en) | 2008-04-30 |
| JP2008505870A (ja) | 2008-02-28 |
| NZ551841A (en) | 2009-04-30 |
| CN1984654A (zh) | 2007-06-20 |
| HRP20080612T3 (hr) | 2009-01-31 |
| DE602005009366D1 (de) | 2008-10-09 |
| MXPA06014930A (es) | 2007-02-28 |
| SI1765337T1 (sl) | 2009-02-28 |
| BRPI0513051A (pt) | 2008-04-22 |
| EP1765337A1 (de) | 2007-03-28 |
| DK1765337T3 (da) | 2009-01-05 |
| EP1765337B1 (de) | 2008-08-27 |
| ES2313394T3 (es) | 2009-03-01 |
| AU2005261701A1 (en) | 2006-01-19 |
| CA2572551A1 (en) | 2006-01-19 |
| US20070208009A1 (en) | 2007-09-06 |
| WO2006005720A1 (en) | 2006-01-19 |
| RU2368380C2 (ru) | 2009-09-27 |
| RU2007104774A (ru) | 2008-08-20 |
| ATE406161T1 (de) | 2008-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05002814A (es) | Formulacion para agentes lipofilicos. | |
| NO20042298L (no) | Farmasoytiske preparater og deres anvendelser | |
| TR200101103T2 (tr) | CGMP PDE-İnhibitörü içeren kontrollu serbest bırakılan farmasötik formülasyonlar | |
| NO20045323L (no) | Antistoffer | |
| PT1318791E (pt) | Composicao farmaceutica semi-solida de isotretinoina | |
| MY142948A (en) | Benzophenones as inhibitors of reverse transcriptase | |
| TR200103575T2 (tr) | Sülfonamid ve sülfamid ikameli/katkılı imidazokinolinler | |
| HUP0300590A2 (hu) | Peptidázzal hasítható, célzott antineoplasztikus szerek és terápiás alkalmazásuk | |
| MY144318A (en) | Methods of treating hiv infection. | |
| ATE210988T1 (de) | Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen | |
| DE60216305D1 (de) | Zusammensetzungen zur verabreichung von arzneimittelkombinationen | |
| PT1594833E (pt) | Derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas | |
| DE60313004D1 (de) | Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination | |
| SI1765337T1 (sl) | Kombinacija tenofovirja, ritonavirja in TMC114 | |
| WO2007013047A3 (en) | Water-dispersible anti-retroviral pharmaceutical compositions | |
| EP4566629A3 (de) | Verwendung von niedervolumigem plasmaaustausch zur behandlung von morbus alzheimer in frühen und mittleren phasen | |
| CO5660287A2 (es) | Derivados de tetrahidrocarbazol y su uso farmaceutico | |
| WO2004041158A3 (en) | Rifalazil compositions and therapeutic regimens | |
| WO2006034001A3 (en) | Methods of treating hiv infection | |
| AU6469401A (en) | Pharmaceutically active compounds and methods of use | |
| IS8051A (is) | Kladríbínefnablöndur til inngjafar um munn | |
| NO983437D0 (no) | Administreringsformer med umiddelbar frigivelse, samt fremgangsmÕte for fremstilling av slike | |
| MY134019A (en) | Aryl oxime-piperazines useful as ccr5 antagonists | |
| AU6415994A (en) | Substituted caprolactams and derivatives thereof useful for treatment of hiv disease | |
| AP2001002369A0 (en) | Pharmaceutical complex. |